USPTO trademark

LEVALTA

RegisteredUSPTOWord markClass 3Class 5Class 10

"LEVALTA" is a word mark owned by Bausch Health Ireland Limited, filed at the USPTO on April 25, 2021. It is registered and covers classes 3, 5 and 10.

View Bausch Health Ireland Limited portfolioGet this data via the API
Official USPTO record
LEVALTA trademark as filed
As filed with the USPTO
Status
Registered
Since December 17, 2024
Filed
April 25, 2021
Registered
December 17, 2024
Priority date
April 1, 2021
Claimed from Ireland
Application no.
90669891
Registration no.
7602935
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns LEVALTA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Bausch Health Ireland Limited

Dublin, Ireland

1,441 trademarks in the portfolioView company

Representative

Jeremy Blackowicz

Bausch Health Companies

Goods and services

What the mark covers

The products and services LEVALTA is filed for, grouped by Nice class.

  • Non-medicated preparations for the skin, namely, moisturizers, creams, body powders, gels, shampoos, sprays, and body washes; Non-medicated dental rinses for oral health

  • Topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and soft tissue regeneration; Medicated dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases in the nature of Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections; Vitamins and mineral supplements; Non-medicated dermatologic substances and preparations for the skin, namely, ointments to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses; Non-medicated oral health substances preparations in the form of tooth and mouth powders, creams, and rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers; Cotton swabs impregnated with non-medicated dermatologic skin care preparations for treating atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses

  • Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Assignment of ownership not updated automatically
  2. Assignment of ownership not updated automatically
  3. Notice of registration confirmation emailed
  4. Registered-principal register
  5. Official gazette publication confirmation e-mailed
  6. Published for opposition
  7. Notification of notice of publication e-mailed
  8. Case returned to examination
  9. Notice of allowance cancelled
  10. Petition to director - change basis - granted

10 earlier steps on the official record.

FAQ

About LEVALTA

Who owns the trademark "LEVALTA"?

The USPTO trademark "LEVALTA" (application 90669891) is owned by Bausch Health Ireland Limited.

What is the status of "LEVALTA"?

Its status at the USPTO is: registered.

When was "LEVALTA" registered?

It was registered on December 17, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LEVALTA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d44-4c94-705b-bfca-d9b3d8ddc4cb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d44-4c94-705b-bfca-d9b3d8ddc4cb",
  "object": "trademark",
  "mark_text": "LEVALTA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90669891",
  "filing_date": "2021-04-25",
  "nice_classes": [
    3,
    5,
    10
  ],
  "owners": [
    {
      "name": "Bausch Health Ireland Limited",
      "entity_id": "ent_019eb74b-d532-753c-a2c4-06325b5a2591"
    }
  ]
}